Site icon Impactiviti

Impactiviti Daily 042710 Top Pharma News



The name is changed, but the pump remains the same – Kapidex (proton pump inhibitor from Takeda) is now Dexilant.

Covidien launches Exalgo (pain reliefe) and Pennsaid (NSAID anti-inflammatory).

FDA panel to Acura: Nah – It was red faces all around at Acura Pharmaceuticals Thursday after an advisory committee voted almost unanimously not to recommend approval of the group’s lead product Acurox, an instant release, tamper resistant form of oxycodone. In a damning and decisive looking 19-1 poll, the committee highlighted the fact that the niacin used to deter abuse by producing painful facial flushing if the drug was crushed and sorted or taken excessively orally, could easily be counteracted by eating food or taking aspirinmore


Emotional Intelligence Training – Emotional intelligence – it doesn’t always come naturally. Proven and successful programs are available from Impactiviti’s partner network.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.


Decades to learn, 90 minutes to write, 7 minutes to read. Seven Profound Business Truths (quick e-book).


This one had me laughing uncontrollably. If you like scientific-sounding verbiage accented by a droll and deadpan delivery, you’ll love this.


Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)


Exit mobile version